A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters
about
Defining the blanks--pharmacochaperoning of SLC6 transporters and ABC transportersRecognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transportersInsulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasisMonoamine TransportSubcellular localization of the antidepressant-sensitive norepinephrine transporter.Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.Postural orthostatic tachycardia syndrome: a dermatologic perspective and successful treatment with losartan.Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorderExpression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.Regulation of monoamine transporters: Role of transporter phosphorylation.Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humansThe serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.Choline transporter gene variation is associated with attention-deficit hyperactivity disorder.Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridizationRegulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.The solute carrier 6 family of transportersDifferential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.Dominant protein interactions that influence the pathogenesis of conformational diseases.Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasksVesicular and plasma membrane transporters for neurotransmitters.Stereoselective inhibition of serotonin transporters by antimalarial compounds.Glycine transporter dimers: evidence for occurrence in the plasma membrane.Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.A cytosolic relay of heat shock proteins HSP70-1A and HSP90β monitors the folding trajectory of the serotonin transporter.Transmembrane topology and oligomeric structure of the high-affinity choline transporter.Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behaviorPharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism.Relax, Cool Down and Scaffold: How to Restore Surface Expression of Folding-Deficient Mutant GPCRs and SLC6 Transporters.Polymorphism of SLC6A2 gene does not influence outcome of myocardial 123I-mIBG scintigraphy in patients with chronic heart failure.
P2860
Q26825537-CB8C6341-8439-426D-B70F-FB38756832AFQ28476265-A4A9721E-89E3-456D-8C15-B43064E97F2EQ28483930-32FD69B0-DBF5-4186-B691-FC2C8BA74E78Q30230904-362CBC61-75F3-45BC-BDC9-48A3A0138683Q30439090-7B0C97EC-626A-4D1B-B33C-9197EFD1A42FQ33162642-CF760CCF-880B-4088-A5FD-48BB3569EE4BQ33164671-335EFDBB-99A4-470A-B635-1DD1F076631DQ33571104-A07D4BAC-A53F-4E73-A39B-2617F3CAB58CQ33654253-15DBE6B1-CAE8-4778-86FC-00E5A1427DA8Q34540543-1B50B836-73F9-414F-93B5-61D3E63E842FQ34731144-66E7D1DD-77FD-4573-949A-365D52764641Q34963789-5088D7DE-EBAB-49C3-8D02-687DD86032E9Q35187232-0953533C-C3E6-48B9-8EA4-F24B739567E3Q35229337-BB582883-EE96-4320-9CC6-EBD9E4B3B9F7Q35234897-A023B9FB-10AF-4AD7-A75A-FC1F97E366C5Q36341704-31A224A2-58D9-401A-8D24-CD76DA60A5CAQ36346899-13FEDD05-B698-410C-8E8D-B1388A67F1AEQ36674628-C140DD39-B743-4121-8CD6-7C3F1F3DE5D6Q36966865-90F85E13-2232-4D01-8AC6-1DC7747FABABQ37451921-19304008-576B-49D0-83F9-906A39598797Q37971367-5C6BC876-DC99-48DB-ACAE-26F0724FAE8FQ41364370-3B3803BC-D131-4064-B72F-FD79A881E847Q41658029-D7805717-8555-4093-95D7-A5410267D0D4Q42226842-CFC135DD-A68D-405D-B485-AC338AE4CC12Q42272217-BF212441-E62C-4AC6-8F9D-2B700E705F4BQ42410778-EDF20F8E-58A5-4AE5-8A8F-C0A4F66852FAQ42446087-BC8BF36D-2D7A-40BA-BA00-0390826DEC3EQ47127983-C716B5B2-106E-437F-AD01-19A1D4C8633BQ47141268-9B6DAB8A-204D-4B9B-A6E7-D469FA681437Q55222178-FD264D71-C3E8-4202-8EC6-F94629CA57CD
P2860
A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters
description
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Juni 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/06/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/06/01)
@nl
наукова стаття, опублікована в червні 2003
@uk
مقالة علمية (نشرت في يونيو 2003)
@ar
name
A mutation in the human norepi ...... ant and wild-type transporters
@ast
A mutation in the human norepi ...... ant and wild-type transporters
@en
A mutation in the human norepi ...... ant and wild-type transporters
@nl
type
label
A mutation in the human norepi ...... ant and wild-type transporters
@ast
A mutation in the human norepi ...... ant and wild-type transporters
@en
A mutation in the human norepi ...... ant and wild-type transporters
@nl
prefLabel
A mutation in the human norepi ...... ant and wild-type transporters
@ast
A mutation in the human norepi ...... ant and wild-type transporters
@en
A mutation in the human norepi ...... ant and wild-type transporters
@nl
P2093
P1476
A mutation in the human norepi ...... ant and wild-type transporters
@en
P2093
David Robertson
Maureen K Hahn
Randy D Blakely
P304
P356
10.1523/JNEUROSCI.23-11-04470.2003
P407
P577
2003-06-01T00:00:00Z